Results 1 to 10 of about 120,578 (342)

Viral Hepatitis and Rapid Diagnostic Test Based Screening for HBsAg in HIV-infected Patients in Rural Tanzania. [PDF]

open access: yesPLoS ONE, 2013
\ud \ud Co-infection with hepatitis B virus (HBV) is highly prevalent in people living with HIV in Sub-Saharan Africa. Screening for HBV surface antigen (HBsAg) before initiation of combination antiretroviral therapy (cART) is recommended. However, it is
AM Geretti   +36 more
core   +21 more sources

HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure

open access: yesViruses, 2022
Despite the availability of effective vaccines and antiviral therapy over the past two to three decades, chronic hepatitis B virus (HBV) infection remains a major global health threat as a leading cause of cirrhosis and liver cancer.
M. Moini, S. Fung
semanticscholar   +1 more source

SERUM HSP 70 LEVELS OF CHRONIC HEPATITIS B PATIENTS ARE SUBSTANTIALLY CORRELATED WITH HBsAg [PDF]

open access: yesEuromediterranean Biomedical Journal, 2020
Heat-shock protein 70 (HSP70) is a stress-induced protein that demonstrates the anti-apoptosis response that ensures the survival of cells. The aim of this study is to investigate the significant correlation of serum HSP70 levels in chronic hepatitis B ...
Awaz Saadi
doaj   +1 more source

Performance Evaluation of an Improved HBsAg Assay (HBsAg NEXT) for the Detection of HBsAg Levels

open access: yesJournal of Laboratory Physicians, 2023
Abstract Objectives Detection of hepatitis B surface antigen (HBsAg) plays an important role in the screening and diagnosis of hepatitis B virus (HBV) infections. There is a need of highly sensitive assays with an improved lower limit of detection (LoD).
Ekta Gupta   +6 more
openaire   +3 more sources

Impact of HBsAg and HBcrAg levels on phenotype and function of HBV-specific T cells in patients with chronic hepatitis B virus infection

open access: yesGut, 2021
Objective Hepatitis B virus (HBV)-specific T cells are main effector cells in the control of HBV infection and hepatitis B surface antigen (HBsAg) is suggested to be a critical factor in the impaired immune response, a hallmark of chronic HBV infection ...
E. Aliabadi   +9 more
semanticscholar   +1 more source

HBsAg in placements

open access: bronzeAmerican Journal of Obstetrics and Gynecology, 1990
Ho‐Hsiung Lin
openaire   +3 more sources

Distribution of ABO, Rhesus Blood Groups, Transfusion Transmitted Diseases and Adverse Donor Reactions in a Blood Bank of a Tertiary Care Hospital: A Five Year Study [PDF]

open access: yesNational Journal of Laboratory Medicine, 2016
Introduction: Study of the distribution of A, B, O blood group systems is essential for genetic studies, medico – legal issues and importantly for efficient delivery of blood bank services. Also important is the immunologic safety of the donated blood
Lekha Mandodar   +2 more
doaj   +1 more source

Prevalence of transfusion transmitted infection among blood donors in Jigawa state, Nigeria [PDF]

open access: yesMicrobes and Infectious Diseases, 2023
Aim: The study was designed to determine seroprevalence of Transfusion transmissible diseases (TTD) among blood donors attending general hospitals in Jigawa Nigeria. Methods: Four hundred blood donors were screened for Malaria parasite, Hepatitis B viral
Bello Garba   +3 more
doaj   +1 more source

PreHevbrio: the first approved 3-antigen hepatitis B vaccine

open access: yesExpert Review of Vaccines, 2023
Introduction Hepatitis B remains a major cause of death and morbidity worldwide. Universal childhood immunization programs have been very successful, but many adults remain unprotected or are not optimally protected.
Timo Vesikari   +3 more
doaj   +1 more source

IL-10 Promoter Polymorphism Distribution among HBsAg-Reactive and HBsAg-Nonreactive Blood Donors

open access: yesMajalah Kedokteran Bandung, 2020
Hepatitis B surface antigen (HBsAg) serves as a serological marker for Hepatitis B virus (HBV) infection. People with HBV asymptomatic infection might readily donate blood due to the lack of clinical manifestations.
Rahmat Azhari Kemal   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy